ACORN is a <a href="https://wellcome.ac.uk" target="_blank">Wellcome</a> funded project led by the Mahidol-Oxford Tropical Medicine Research Unit (<a href="http://www.tropmedres.ac/home" target="_blank">MORU</a>) and the Oxford University of Oxford Clinical Research Unit (<a href="http://www.oucru.org" target="_blank">OUCRU</a>). The pilot phase of ACORN will focus on development, implementation and assessment of enhanced antimicrobial resistance (AMR) surveillance, including collection of relevant clinical metadata and denominators, as part of routine clinical care in three hospitals in southeast Asia.